Why Are Nexalin Technology Shares Surging Friday?
Portfolio Pulse from Vaishali Prayag
Nexalin Technology, Inc. (NASDAQ:NXL) shares surged by 97.3% following the announcement of a new patent for its Deep Intracranial Frequency Stimulation (DIFS) device, aimed at treating Alzheimer's and dementia. The patent expands the company's intellectual property and highlights the potential of DIFS technology in the mental health market.
June 21, 2024 | 5:54 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Nexalin Technology's shares surged by 97.3% after the USPTO granted a new patent for its DIFS device, which targets Alzheimer's and dementia. This development significantly enhances the company's intellectual property and market potential.
The new patent for the DIFS device is a significant milestone for Nexalin Technology, enhancing its intellectual property portfolio and opening up substantial market opportunities in the treatment of Alzheimer's and dementia. The market's positive reaction, with a 97.3% surge in share price, reflects investor confidence in the potential of this technology.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100